18F-Fluorodeoxyglucose-positron emission tomography and pathologic tumor size in early-stage invasive cervical cancer

International Journal of Gynecological Cancer

Volumn 19, Issue 8, 2009, Pages 1412-1414

  Showalter, Timothy N ^a   Miller, Tom R ^b,c   Huettner, Phyllis ^a,c   Rader, Janet ^a,c   Grigsby, Perry W ^a,b,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c USA   (United States)

Author keywords

Cervical cancer; FDG PET; Hysterectomy; Tumor diameter

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER INVASION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE DISSECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; TUMOR VOLUME; UTERINE CERVIX CANCER; ADENOCARCINOMA; CANCER STAGING; COHORT ANALYSIS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; SCINTISCANNING; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX TUMOR;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED; UTERINE CERVICAL NEOPLASMS;

EID: 73349110081     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181b62e8c     Document Type: Article

References (10)

1. Pecorelli S, Zigliani L, Odicino F. Revised FIGO staging for carcinoma of the cervix. Int J Gynaecol Obstet. 2009;105:107-108.
2. Narayan K, Fisher R, Bernshaw D. Significance of tumor volume and corpus uteri invasion in cervical cancer patients treated by radiotherapy. Int J Gynecol Cancer. 2006;16:623-630.
3. Narayan K, McKenzie A, Fisher R, et al. Estimation of tumor volume in cervical cancer by magnetic resonance imaging. Am J Clin Oncol. 2003;26:e163-e168.
4. Grigsby PW, Siegel BA, Dehdashti F. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol. 2001;19:3745-3749.
5. Miller TR, Grigsby PW. Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy. Int J Radiat Oncol Biol Phys. 2002;53:353-359.
6. Schwarz JK, Siegel BA, Dehdashti F, et al. Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma. JAMA. 2007;298:2289-2295.
7. Follen M, Levenback CF, Iyer RB, et al. Imaging in cervical cancer. Cancer. 2003;98:2028-2038.
8. Subak LL, Hricak H, Powell CB, et al. Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging. Obstet Gynecol. 1995;86:43-50.
9. Soret M, Bacharach SL, Buvat I. Partial-volume effect in PET tumor imaging. J Nucl Med. 2007;48:932-945.
10. Grills IS, Yan D, Black QC, et al. Clinical implications of defining the gross tumor volume with combination of CT and 18FDG-positron emission tomography in nonYsmall-cell lung cancer. Int J Radiat Oncol Biol Phys. 2007;67:709-719.